SUZ12 and malignant peripheral nerve sheath tumor: Evidence for this was seen upon treatment of MPNST cell lines with JQ1, a bromodomain inhibitor, where a similar effect on RAS signatures as SUZ12 reconstitution was noted in the PRC2-deficient cells.